FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304823076> ?p ?o ?g. }

• W4304823076 abstract "Background and Objectives: Preeclampsia is a multisystem disorder that affects maternal endothelium. The glycocalyx lines and protects the endothelial surface. In severe systemic diseases, like sepsis, it is shed and glycocalyx degradation products can be detected in increased concentrations in plasma. The aim of this study was to compare circulating concentrations of glycocalyx degradation products in degrees of preeclampsia severity. Study design : In this observational study, we included women from the South African PROVE biobank. Women were divided into normotensive controls, women with preeclampsia without end-organ complications, women with a single end-organ complication and women with multiple end-organ complications. Plasma samples taken at inclusion after diagnosis (preeclampsia cases) or at admission for delivery (normotensive controls) were analyzed with ELISA for syndecan-1, hyaluronic acid and thrombomodulin and compared between groups. Results: Women with preeclampsia ( n = 47) had increased plasma concentrations of hyaluronic acid (100.3 ng/ml IQR 54.2–204 vs . 27.0 ng/ml IQR (13.5–66.6), p &lt; 0,001) and thrombomodulin (4.22 ng/ml IQR 3.55–5.17 vs . 3.49 ng/ml IQR 3.01–3.68, p = 0.007) but not syndecan-1 compared with normotensive women ( n = 10). There were no differences in plasma concentration in any of these biomarkers in women with preeclampsia with no end-organ complications ( n = 10) compared with women with preeclampsia and one end-organ complication ( n = 24). Women with preeclampsia with two or more end-organ complications ( n = 13) had increased plasma concentrations of thrombomodulin (5.46 ng/ml, IQR 4.85–7.83 vs . 4.66 ng/ml, IQR 3.45–4.88, p = 0.042) compared with women with preeclampsia and no end-organ complications. Conclusion: Thrombomodulin was associated with disease severity and may be valuable for risk-stratifying women with preeclampsia." @default.
• W4304823076 created "2022-10-13" @default.
• W4304823076 creator A5005392280 @default.
• W4304823076 creator A5007537451 @default.
• W4304823076 creator A5029453988 @default.
• W4304823076 creator A5041776704 @default.
• W4304823076 creator A5047539235 @default.
• W4304823076 creator A5055931043 @default.
• W4304823076 creator A5070233673 @default.
• W4304823076 date "2022-10-13" @default.
• W4304823076 modified "2023-10-18" @default.
• W4304823076 title "Circulating concentrations of glycocalyx degradation products in preeclampsia" @default.
• W4304823076 cites W1578062386 @default.
• W4304823076 cites W188389244 @default.
• W4304823076 cites W2000187168 @default.
• W4304823076 cites W2012884454 @default.
• W4304823076 cites W2021804116 @default.
• W4304823076 cites W2030469264 @default.
• W4304823076 cites W2045842626 @default.
• W4304823076 cites W2060154131 @default.
• W4304823076 cites W2061506872 @default.
• W4304823076 cites W2064974006 @default.
• W4304823076 cites W2080736461 @default.
• W4304823076 cites W2081122835 @default.
• W4304823076 cites W2085507038 @default.
• W4304823076 cites W2099328660 @default.
• W4304823076 cites W2108515681 @default.
• W4304823076 cites W2141810086 @default.
• W4304823076 cites W2144795734 @default.
• W4304823076 cites W2289813931 @default.
• W4304823076 cites W2422850516 @default.
• W4304823076 cites W2509095239 @default.
• W4304823076 cites W2802821737 @default.
• W4304823076 cites W2913691982 @default.
• W4304823076 cites W2944434778 @default.
• W4304823076 cites W2963630514 @default.
• W4304823076 cites W2970423612 @default.
• W4304823076 cites W2978389459 @default.
• W4304823076 cites W2980322225 @default.
• W4304823076 cites W3000388286 @default.
• W4304823076 cites W3132015108 @default.
• W4304823076 cites W3156416917 @default.
• W4304823076 cites W4206731013 @default.
• W4304823076 cites W4211032164 @default.
• W4304823076 doi "https://doi.org/10.3389/fphys.2022.1022770" @default.
• W4304823076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36311221" @default.
• W4304823076 hasPublicationYear "2022" @default.
• W4304823076 type Work @default.
• W4304823076 citedByCount "3" @default.
• W4304823076 countsByYear W43048230762023 @default.
• W4304823076 crossrefType "journal-article" @default.
• W4304823076 hasAuthorship W4304823076A5005392280 @default.
• W4304823076 hasAuthorship W4304823076A5007537451 @default.
• W4304823076 hasAuthorship W4304823076A5029453988 @default.
• W4304823076 hasAuthorship W4304823076A5041776704 @default.
• W4304823076 hasAuthorship W4304823076A5047539235 @default.
• W4304823076 hasAuthorship W4304823076A5055931043 @default.
• W4304823076 hasAuthorship W4304823076A5070233673 @default.
• W4304823076 hasBestOaLocation W43048230761 @default.
• W4304823076 hasConcept C105702510 @default.
• W4304823076 hasConcept C126322002 @default.
• W4304823076 hasConcept C134018914 @default.
• W4304823076 hasConcept C16685009 @default.
• W4304823076 hasConcept C201267052 @default.
• W4304823076 hasConcept C203014093 @default.
• W4304823076 hasConcept C2776246508 @default.
• W4304823076 hasConcept C2776992346 @default.
• W4304823076 hasConcept C2777218350 @default.
• W4304823076 hasConcept C2777292125 @default.
• W4304823076 hasConcept C2777529286 @default.
• W4304823076 hasConcept C2778384902 @default.
• W4304823076 hasConcept C2778426790 @default.
• W4304823076 hasConcept C2779234561 @default.
• W4304823076 hasConcept C2780098789 @default.
• W4304823076 hasConcept C54355233 @default.
• W4304823076 hasConcept C71924100 @default.
• W4304823076 hasConcept C81182388 @default.
• W4304823076 hasConcept C86803240 @default.
• W4304823076 hasConcept C89560881 @default.
• W4304823076 hasConcept C90924648 @default.
• W4304823076 hasConceptScore W4304823076C105702510 @default.
• W4304823076 hasConceptScore W4304823076C126322002 @default.
• W4304823076 hasConceptScore W4304823076C134018914 @default.
• W4304823076 hasConceptScore W4304823076C16685009 @default.
• W4304823076 hasConceptScore W4304823076C201267052 @default.
• W4304823076 hasConceptScore W4304823076C203014093 @default.
• W4304823076 hasConceptScore W4304823076C2776246508 @default.
• W4304823076 hasConceptScore W4304823076C2776992346 @default.
• W4304823076 hasConceptScore W4304823076C2777218350 @default.
• W4304823076 hasConceptScore W4304823076C2777292125 @default.
• W4304823076 hasConceptScore W4304823076C2777529286 @default.
• W4304823076 hasConceptScore W4304823076C2778384902 @default.
• W4304823076 hasConceptScore W4304823076C2778426790 @default.
• W4304823076 hasConceptScore W4304823076C2779234561 @default.
• W4304823076 hasConceptScore W4304823076C2780098789 @default.
• W4304823076 hasConceptScore W4304823076C54355233 @default.
• W4304823076 hasConceptScore W4304823076C71924100 @default.
• W4304823076 hasConceptScore W4304823076C81182388 @default.
• W4304823076 hasConceptScore W4304823076C86803240 @default.
• W4304823076 hasConceptScore W4304823076C89560881 @default.

• next